Literature DB >> 29128013

Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.

Anne Bergeron1, Guang-Shing Cheng2.   

Abstract

As more individuals survive their hematologic malignancies after allogeneic hematopoietic stem cell transplantation (HSCT), there is growing appreciation of the late organ complications of this curative procedure for malignant and nonmalignant hematologic disorders. Late noninfectious pulmonary complications encompass all aspects of the bronchopulmonary anatomy. There have been recent advances in the diagnostic recognition and management of bronchiolitis obliterans syndrome, which is recognized as a pulmonary manifestation of chronic graft-versus-host disease. Organizing pneumonia and other interstitial lung diseases are increasingly recognized. This article provides an update on these entities as well as pleural and pulmonary vascular disease after allogeneic HSCT.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplant; Bronchiolitis obliterans syndrome; Graft-versus-host disease; Interstitial lung disease; Obliterative bronchiolitis; Organizing pneumonia; Pleuroparenchymal fibroelastosis

Mesh:

Year:  2017        PMID: 29128013     DOI: 10.1016/j.ccm.2017.07.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  14 in total

1.  Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Guang-Shing Cheng; Katherine E Selwa; Charles Hatt; Sundaresh Ram; Aleksa B Fortuna; Margaret Guerriero; Ben Himelhoch; Daniel McAree; Timothy C Hoffman; Joseph Brisson; Ryan Nazareno; Kiernan Bloye; Timothy D Johnson; Mats Remberger; Jonas Mattsson; Dharshan Vummidi; Ella E Kazerooni; Vibha N Lama; Stefanie Galban; Michael Boeckh; Gregory A Yanik; Craig J Galban
Journal:  Am J Transplant       Date:  2020-03-06       Impact factor: 8.086

2.  MiR-27a-3p downregulation contributes to the development of occlusive bronchiolitis.

Authors:  Ming Dong; Xin Wang; Yong Guan; Tong Li
Journal:  Cell Stress Chaperones       Date:  2019-08-27       Impact factor: 3.667

3.  Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.

Authors:  Guang-Shing Cheng; Louise Bondeelle; Ted Gooley; Qianchuan He; Kareem Jamani; Elizabeth F Krakow; Mary E D Flowers; Régis Peffault de Latour; David Michonneau; Gérard Socié; Jason W Chien; Sylvie Chevret; Anne Bergeron
Journal:  Biol Blood Marrow Transplant       Date:  2019-11-01       Impact factor: 5.742

Review 4.  Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies.

Authors:  Courtney D Fitzhugh; Emmanuel J Volanakis; Ombeni Idassi; Josh A Duberman; Michael R DeBaun; Debra L Friedman
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

5.  Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Sagar S Patel; Kwang Woo Ahn; Manoj Khanal; Caitrin Bupp; Mariam Allbee-Johnson; Navneet S Majhail; Betty K Hamilton; Seth J Rotz; Hasan Hashem; Amer Beitinjaneh; Hillard M Lazarus; Maxwell M Krem; Tim Prestidge; Neel S Bhatt; Akshay Sharma; Shahinaz M Gadalla; Hemant S Murthy; Larisa Broglie; Taiga Nishihori; César O Freytes; Gerhard C Hildebrandt; Usama Gergis; Sachiko Seo; Baldeep Wirk; Marcelo C Pasquini; Bipin N Savani; Mohamed L Sorror; Edward A Stadtmauer; Saurabh Chhabra
Journal:  Transplant Cell Ther       Date:  2022-03-18

6.  Prevalence of Ototoxicity Following Hematopoietic Stem Cell Transplantation in Pediatric Patients.

Authors:  Kristen Gertson; Susan S Hayashi; Kathryn Trinkaus; Fei Wan; Robert J Hayashi
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-05       Impact factor: 5.742

7.  Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary.

Authors:  Robert F Tamburro; Kenneth R Cooke; Stella M Davies; Samuel Goldfarb; James S Hagood; Ashok Srinivasan; Marie E Steiner; Dennis Stokes; Nancy DiFronzo; Nahed El-Kassar; Nonniekaye Shelburne; Aruna Natarajan
Journal:  Ann Am Thorac Soc       Date:  2021-03

Review 8.  Quantitative inspiratory-expiratory chest CT to evaluate pulmonary involvement in pediatric hematopoietic stem-cell transplantation patients.

Authors:  Francesca Pennati; Laura L Walkup; Anuj Chhabra; Christopher Towe; Kasiani Myers; Andrea Aliverti; Jason C Woods
Journal:  Pediatr Pulmonol       Date:  2020-12-23

9.  Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease.

Authors:  Jane Turner; Qianchuan He; Kelsey Baker; Lisa Chung; Adrian Lazarevic-Fogelquist; Danika Bethune; Jesse Hubbard; Margaret Guerriero; Ajay Sheshadri; Karen L Syrjala; Paul J Martin; Michael Boeckh; Stephanie J Lee; Ted Gooley; Mary E Flowers; Guang-Shing Cheng
Journal:  Transplant Cell Ther       Date:  2021-03-26

10.  Pre-Hematopoietic Stem Cell Transplantation Lung Computed Tomography as an Alternative to the Pulmonary Function Test during the COVID-19 Pandemic.

Authors:  Masaharu Tamaki; Hideki Nakasone; Tadao Aikawa; Yuhei Nakamura; Masakatsu Kawamura; Shunto Kawamura; Junko Takeshita; Nozomu Yoshino; Yukiko Misaki; Kazuki Yoshimura; Shinpei Matsumi; Ayumi Gomyo; Aki Tanihara; Machiko Kusuda; Yu Akahoshi; Shun-Ichi Kimura; Shinichi Kako; Noriko Oyama-Manabe; Yoshinobu Kanda
Journal:  Biol Blood Marrow Transplant       Date:  2020-08-27       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.